{"organizations": [], "uuid": "6c1f3d1cdb724a1784871bb855421661884b33ac", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180302.html", "section_title": "Archive News &amp; Video for Friday, 02 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-zosano-pharma-announces-issuance-o/brief-zosano-pharma-announces-issuance-of-new-u-s-patent-covering-m207-as-an-acute-treatment-for-migraine-idUSFWN1QK0QR", "country": "US", "domain_rank": 408, "title": "BRIEF-Zosano Pharma Announces Issuance Of New U.S. Patent Covering M207 As An Acute Treatment For Migraine", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.907, "site_type": "news", "published": "2018-03-02T21:34:00.000+02:00", "replies_count": 0, "uuid": "6c1f3d1cdb724a1784871bb855421661884b33ac"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-zosano-pharma-announces-issuance-o/brief-zosano-pharma-announces-issuance-of-new-u-s-patent-covering-m207-as-an-acute-treatment-for-migraine-idUSFWN1QK0QR", "ord_in_thread": 0, "title": "BRIEF-Zosano Pharma Announces Issuance Of New U.S. Patent Covering M207 As An Acute Treatment For Migraine", "locations": [], "entities": {"persons": [{"name": "coveri", "sentiment": "negative"}], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "new u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-zosano pharma", "sentiment": "negative"}, {"name": "zosano pharma corp", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 2 (Reuters) - Zosano Pharma Corp:\n* ZOSANO PHARMA ANNOUNCES ISSUANCE OF NEW U.S. PATENT COVERING M207 AS AN ACUTE TREATMENT FOR MIGRAINE Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-02T21:34:00.000+02:00", "crawled": "2018-03-03T17:32:09.002+02:00", "highlightTitle": ""}